Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Biomarkers of Haemostasis and Occurrence of Venous Thromboembolism Are Associated with Disease Progression and Poor Prognosis in Patients with Pancreatic Cancer

Florian Moik, MD, Gerald Prager, MD, Sarah Wiedemann, Florian Posch, MD MSc, PhD, Ingrid Pabinger, MD, Cihan Ay, MD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-141239

Published: 2020

Journal Articles

Association of ABO Blood Group with Bleeding Severity in Patients with Bleeding of Unknown Cause

Dino Mehic, MD, Stefanie Hofer, PhD, Christof Jungbauer, MD, Alexandra Kaider, Helmuth Haslacher, MD, Ernst Eigenbauer, Judit Rejtoe, MD, Dieter Schwartz, MD, Bernd Jilma, Cihan Ay, MD, Ingrid Pabinger, MD, Johanna Gebhart, MD PhD

Blood (2020) 136 (Supplement 1): 16–18.

https://doi.org/10.1182/blood-2020-137378

Published: 2020

Journal Articles

Factor VIII Levels in Blood Group O and Non-O in Patients with Non-Severe Haemophilia a

Judit Rejtoe, MD, Oliver Königsbrügge, MD, Ella Grilz, MD, Stefanie Hofer, Johanna Gebhart, MD, Gerhard Schuster, MD, Clemens Feistritzer, MD, Peter Quehenberger, MD, Cihan Ay, MD, Ingrid Pabinger, MD

Blood (2019) 134 (Supplement_1): 1135.

https://doi.org/10.1182/blood-2019-123187

Published: 2019

Journal Articles

The Role of Neutrophil Extracellular Traps in Cancer-Associated Arterial Thrombosis

Ella Grilz, MD, Lisa-Marie Mauracher, MSc, Oliver Königsbrügge, MD PhD, Florian Posch, MD MSc, Irene Lang, MD, Ingrid Pabinger, MD, Cihan Ay, MD

Blood (2018) 132 (Supplement 1): 2508.

https://doi.org/10.1182/blood-2018-99-116104

Published: 2018

Journal Articles

Decrease in Overall and Joint Bleeding Rates with Extended-Interval Dosing: > 4 Years of Bay 94-9027 Prophylaxis in the Protect VIII Extension

Mark T. Reding, MD, Shadan Lalezari, Dr, Ingrid Pabinger, MD, Monica Maas Enriquez, Dr, Jonathan M. Ducore, MD

Blood (2018) 132 (Supplement 1): 1206.

https://doi.org/10.1182/blood-2018-99-116272

Published: 2018

Journal Articles

Longitudinal Haemostatic Biomarker Trajectories Predict Cancer-Associated Venous Thromboembolism

Florian Posch, MD MSc, Julia Riedl, MD, Eva-Maria Reitter, MD, Peter Quehenberger, MD, Cihan Ay, MD, Ingrid Pabinger, MD

Blood (2017) 130 (Supplement 1): 1095.

https://doi.org/10.1182/blood.V130.Suppl_1.1095.1095

Published: 2017

Journal Articles

Comparison of the Effects of the Thrombopoietin (TPO) Receptor Agonist Romiplostim in Patients with Immune Thrombocytopenia (ITP) for ≤1 Year Vs. >1 Year

David J Kuter, MD DPhil, Adrian Newland, Beng H Chong, MBBS, PhD, Francesco Rodeghiero, MD, Monica Tejeda Romero, Ingrid Pabinger, MD, Yuqi Chen, Kejia Wang, Bhakti Mehta, Melissa Eisen

Blood (2017) 130 (Supplement 1): 1055.

https://doi.org/10.1182/blood.V130.Suppl_1.1055.1055

Published: 2017

Journal Articles

Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Adolescents/Adults with Hemophilia B: Long-Term Efficacy and Safety from an Ongoing Phase 3b Extension Clinical Trial

Ingrid Pabinger, MD, Elena Santagostino, Andres Brainsky, MD, Jerry S. Powell, MD, Yanyan Li, PhD, Wilfried Seifert, PhD

Blood (2017) 130 (Supplement 1): 3690.

https://doi.org/10.1182/blood.V130.Suppl_1.3690.3690

Published: 2017

Journal Articles

Clinical Outcomes of Weekly Prophylaxis with rFVIIIFc: Longitudinal Analysis of the A-LONG and ASPIRE Study Population

Amy D. Shapiro, MD, Alok Srivastava, MD, Margaret V. Ragni, MD MPH, Ingrid Pabinger, MD, Stefan Lethagen, Elisa Tsao, Desilu Glazebrook, Doris Quon

Blood (2017) 130 (Supplement 1): 2368.

https://doi.org/10.1182/blood.V130.Suppl_1.2368.2368

Published: 2017

Journal Articles

Highly Procoagulant Extracellular Vesicles in Amniotic Fluid

Johannes Thaler, MDPhD, Lena Hell, MSc, Lukas Wisgrill, MD, Andreas Spittler, MD, Michael Schwameis, MD, Bernd Jilma, MD, Peter Altevogt, MD, Cihan Ay, MD, Ingrid Pabinger, MD

Blood (2016) 128 (22): 4961.

https://doi.org/10.1182/blood.V128.22.4961.4961

Published: 2016

Journal Articles

Annexin A5 Resistance Is Associated with Thrombotic Risk in Patients with the Lupus Anticoagulant: The Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Florian Posch, MDMSc, Johanna Gebhart, MD, Wu Xiao-Xuan, PhD, Silvia Koder, Cihan Ay, MD, Jacob H. Rand, MD, Ingrid Pabinger, MD

Blood (2015) 126 (23): 3555.

https://doi.org/10.1182/blood.V126.23.3555.3555

Published: 2015

Journal Articles

Rviii-Singlechain Pharmacokinetics and Safety in Children Less Than 12 Years of Age

Claudia Djambas Khayat, MD BS, Oleksandra Stasyshyn, MD, Genadi Iosava, Prof., D.M., Ph. D., Jeannie B Ong, MD, Faraizah Abdul Karim, MD, Debra M. Bensen-Kennedy, MD, Katie St. Ledger, MS, Tharin Limsakun, PhD, Alex Veldman, MD, Ingrid Pabinger, MD

Blood (2015) 126 (23): 3524.

https://doi.org/10.1182/blood.V126.23.3524.3524

Published: 2015

Journal Articles

Rviii-Singlechain in Surgical Prophylaxis: Efficacy and Safety of Continuous and Bolus Infusion

Claudia Djambas Khayat, MD BS, Johnny N. Mahlangu, MD, Ross I Baker, MD, Cindy A. Leissinger, MD, Elena Santagostino, MD PhD, Debra M. Bensen-Kennedy, MD, Katie St. Ledger, MS, Alex Veldman, MD, Ingrid Pabinger, MD

Blood (2015) 126 (23): 3525.

https://doi.org/10.1182/blood.V126.23.3525.3525

Published: 2015

Journal Articles

Thrombotic Events in Lupus Anticoagulant Positive Patients Prospectively Correlate with Clinical Risk Factors - the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Florian Posch, MDMSc, Johanna Gebhart, MD, Jacob H. Rand, MD, Bas de Laat, MDPhD, Silvia Koder, Peter Quehenberger, MD, Cihan Ay, Ingrid Pabinger, MD

Blood (2015) 126 (23): 652.

https://doi.org/10.1182/blood.V126.23.652.652

Published: 2015

Journal Articles

Prediction of Venous Thromboembolism in Patients with Cancer By the Activated Partial Thromboplastin Time: Results from the Vienna Cancer and Thrombosis Study

Cihan Ay, MD, Florian Posch, MDMSc, Julia Riedl, MD, Oliver Koenigsbruegge, MD, Peter Quehenberger, MD, Christoph Zielinski, MD, Ingrid Pabinger, MD

Blood (2015) 126 (23): 653.

https://doi.org/10.1182/blood.V126.23.653.653

Published: 2015

Journal Articles

Ristocetin-Induced Platelet Aggregation for Monitoring of Bleeding Tendency in Ibrutinib-Treated Patients with Chronic Lymphocytic Leukemia

Lukas Kazianka, Christa Drucker, Cathrin Skrabs, MD, Philipp Bernhard Staber, MD PhD, Edit Anna Porpaczy, MD PhD, Christine Einberger, Marion Heinz, Alexander Hauswirth, MD, Ingrid Pabinger, MD, Peter Quehenberger, MD, Bernd Jilma, MD, Ulrich Jaeger, MD

Blood (2015) 126 (23): 718.

https://doi.org/10.1182/blood.V126.23.718.718

Published: 2015

Journal Articles

International Good Clinical Practices Guidelines (GCPG) for Antithrombotics in CANCER Patients

Blood (2012) 120 (21): 1161.

https://doi.org/10.1182/blood.V120.21.1161.1161

Published: 2012

Journal Articles

Factor V Leiden Mutation Increases the Risk of Venous Thromboembolism in Cancer Patients – Results From the Vienna Cancer and Thrombosis Study (CATS).

Ingrid Pabinger, MD, Cihan Ay, MD, Daniela Dunkler, Johannes Thaler, Eva-Maria Reitter, Christine Marosi, Christoph Zielinski, Christine Mannhalter

Blood (2012) 120 (21): 2253.

https://doi.org/10.1182/blood.V120.21.2253.2253

Published: 2012

Journal Articles

International Clinical Practice Guidelines for the Treatment and Prophylaxis of Thrombosis Associated with Central Venous Catheters in Patients with Cancer

Blood (2012) 120 (21): 4357.

https://doi.org/10.1182/blood.V120.21.4357.4357

Published: 2012

Journal Articles

Human-Cl Rhfviii Effectively and Safely Prevents Bleeding Episodes in Previously Treated Adult Patients with Severe Haemophilia A

Sigurd Knaub, PhD, Toshko Lissitchkov, MD, PhD, Kingsley Hampton, Mario Von Depka, Savita Rangarajan, MBBS, FRCP, FRCPath, Charles R.M. Hay, MD, FRCP, FRCPath, Edward GD Tuddenham, MBBS, FRCP, FRCPath, PhD, Peter Collins, MD, Katharina Holstein, MD, Angela Huth-Kühne, Ingrid Pabinger, MD, Johannes Oldenburg, MD, Johann Bichler

Blood (2012) 120 (21): 1132.

https://doi.org/10.1182/blood.V120.21.1132.1132

Published: 2012

NARROW

Biomarkers of Haemostasis and Occurrence of Venous Thromboembolism Are Associated with Disease Progression and Poor Prognosis in Patients with Pancreatic Cancer

Association of ABO Blood Group with Bleeding Severity in Patients with Bleeding of Unknown Cause

Factor VIII Levels in Blood Group O and Non-O in Patients with Non-Severe Haemophilia a

The Role of Neutrophil Extracellular Traps in Cancer-Associated Arterial Thrombosis

Decrease in Overall and Joint Bleeding Rates with Extended-Interval Dosing: > 4 Years of Bay 94-9027 Prophylaxis in the Protect VIII Extension

Longitudinal Haemostatic Biomarker Trajectories Predict Cancer-Associated Venous Thromboembolism

Comparison of the Effects of the Thrombopoietin (TPO) Receptor Agonist Romiplostim in Patients with Immune Thrombocytopenia (ITP) for ≤1 Year Vs. >1 Year

Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Adolescents/Adults with Hemophilia B: Long-Term Efficacy and Safety from an Ongoing Phase 3b Extension Clinical Trial

Clinical Outcomes of Weekly Prophylaxis with rFVIIIFc: Longitudinal Analysis of the A-LONG and ASPIRE Study Population

Highly Procoagulant Extracellular Vesicles in Amniotic Fluid

Annexin A5 Resistance Is Associated with Thrombotic Risk in Patients with the Lupus Anticoagulant: The Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Rviii-Singlechain Pharmacokinetics and Safety in Children Less Than 12 Years of Age

Rviii-Singlechain in Surgical Prophylaxis: Efficacy and Safety of Continuous and Bolus Infusion

Thrombotic Events in Lupus Anticoagulant Positive Patients Prospectively Correlate with Clinical Risk Factors - the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Prediction of Venous Thromboembolism in Patients with Cancer By the Activated Partial Thromboplastin Time: Results from the Vienna Cancer and Thrombosis Study

Ristocetin-Induced Platelet Aggregation for Monitoring of Bleeding Tendency in Ibrutinib-Treated Patients with Chronic Lymphocytic Leukemia

International Good Clinical Practices Guidelines (GCPG) for Antithrombotics in CANCER Patients

Factor V Leiden Mutation Increases the Risk of Venous Thromboembolism in Cancer Patients – Results From the Vienna Cancer and Thrombosis Study (CATS).

International Clinical Practice Guidelines for the Treatment and Prophylaxis of Thrombosis Associated with Central Venous Catheters in Patients with Cancer

Human-Cl Rhfviii Effectively and Safely Prevents Bleeding Episodes in Previously Treated Adult Patients with Severe Haemophilia A

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only